These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30767738)

  • 1. Separation, Characterization and Discriminant Analysis of Subvisible Particles in Biologics Formulations.
    Akhunzada ZS; Hubert M; Sahin E; Pratt J
    Curr Pharm Biotechnol; 2019; 20(3):232-244. PubMed ID: 30767738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification and characterization of subvisible proteinaceous particles in opalescent mAb formulations using micro-flow imaging.
    Sharma DK; Oma P; Pollo MJ; Sukumar M
    J Pharm Sci; 2010 Jun; 99(6):2628-42. PubMed ID: 20049937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Label-free flow cytometry analysis of subvisible aggregates in liquid IgG1 antibody formulations.
    Nishi H; Mathäs R; Fürst R; Winter G
    J Pharm Sci; 2014 Jan; 103(1):90-9. PubMed ID: 24218205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Evaluation of Two Methods for Preparative Fractionation of Proteinaceous Subvisible Particles--Differential Centrifugation and FACS.
    Boll B; Folzer E; Finkler C; Huwyler J; Mahler HC; Schmidt R; Koulov AV
    Pharm Res; 2015 Dec; 32(12):3952-64. PubMed ID: 26195006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative High-Throughput Analysis of Subvisible Particles in Biological Formulations Using Backgrounded Membrane Imaging.
    Murphy MI; Bruque M; Hanford A; Trayton I; Handali M; Leissa JA; Hasige S; Day K; Patel SM
    J Pharm Sci; 2022 Jun; 111(6):1605-1613. PubMed ID: 35318031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convolutional Neural Networks Enable Highly Accurate and Automated Subvisible Particulate Classification of Biopharmaceuticals.
    Wang S; Liaw A; Chen YM; Su Y; Skomski D
    Pharm Res; 2023 Jun; 40(6):1447-1457. PubMed ID: 36471026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of solution properties on the counting and sizing of subvisible particle standards as measured by light obscuration and digital imaging methods.
    Werk T; Volkin DB; Mahler HC
    Eur J Pharm Sci; 2014 Mar; 53():95-108. PubMed ID: 24370624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring Subvisible Particles in Protein Formulations Using a Modified Light Obscuration Sensor with Improved Detection Capabilities.
    Ríos Quiroz A; Québatte G; Stump F; Finkler C; Huwyler J; Schmidt R; Mahler HC; Koulov AV; Adler M
    Anal Chem; 2015 Jun; 87(12):6119-24. PubMed ID: 26001042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-flow imaging multi-instrument evaluation for sub-visible particle detection.
    Fawaz I; Schaz S; Boehrer A; Garidel P; Blech M
    Eur J Pharm Biopharm; 2023 Apr; 185():55-70. PubMed ID: 36708971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaborative Study for Analysis of Subvisible Particles Using Flow Imaging and Light Obscuration: Experiences in Japanese Biopharmaceutical Consortium.
    Kiyoshi M; Shibata H; Harazono A; Torisu T; Maruno T; Akimaru M; Asano Y; Hirokawa M; Ikemoto K; Itakura Y; Iwura T; Kikitsu A; Kumagai T; Mori N; Murase H; Nishimura H; Oda A; Ogawa T; Ojima T; Okabe S; Saito S; Saitoh S; Suetomo H; Takegami K; Takeuchi M; Yasukawa H; Uchiyama S; Ishii-Watabe A
    J Pharm Sci; 2019 Feb; 108(2):832-841. PubMed ID: 30121316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closing the Gap: Counting and Sizing of Particles Across Submicron Range by Flow Cytometry in Therapeutic Protein Products.
    Zhang L; Shi S; Antochshuk V
    J Pharm Sci; 2017 Nov; 106(11):3215-3221. PubMed ID: 28625725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Inherent Particles and Mechanism of Thermal Stress Induced Particle Formation in HSV-2 Viral Vaccine Candidate.
    Li L; Kirkitadze M; Bhandal K; Roque C; Yang E; Carpick B; Rahman N
    Curr Pharm Biotechnol; 2017 Nov; 18(8):638-647. PubMed ID: 28914197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of Three Flow Imaging Microscopy Instruments for Image Analysis in Evaluating four Types of Subvisible Particle in Biopharmaceuticals.
    Nishiumi H; Deiringer N; Krause N; Yoneda S; Torisu T; Menzen T; Friess W; Uchiyama S
    J Pharm Sci; 2022 Nov; 111(11):3017-3028. PubMed ID: 35948157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How subvisible particles become invisible-relevance of the refractive index for protein particle analysis.
    Zölls S; Gregoritza M; Tantipolphan R; Wiggenhorn M; Winter G; Friess W; Hawe A
    J Pharm Sci; 2013 May; 102(5):1434-46. PubMed ID: 23463514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subvisible Particle Analysis of 17 Monoclonal Antibodies Approved in China Using Flow Imaging and Light Obscuration.
    Guo S; Yu C; Guo X; Jia Z; Yu X; Yang Y; Guo L; Wang L
    J Pharm Sci; 2022 Apr; 111(4):1164-1171. PubMed ID: 34551350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologically-Directed Raman Spectroscopy as an Analytical Method for Subvisible Particle Characterization in Therapeutic Protein Product Quality.
    Kim M; Ma Y; Srinivasan C; O'Connor T; Telikepalli SN; Ripple DC; Lute S; Bhirde A
    Sci Rep; 2023 Nov; 13(1):20473. PubMed ID: 37993487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of background membrane imaging versus flow technologies for subvisible particle analysis of biologics.
    Vargas SK; Eskafi A; Carter E; Ciaccio N
    Int J Pharm; 2020 Mar; 578():119072. PubMed ID: 32001293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculating the mass of subvisible protein particles with improved accuracy using microflow imaging data.
    Kalonia C; Kumru OS; Prajapati I; Mathaes R; Engert J; Zhou S; Middaugh CR; Volkin DB
    J Pharm Sci; 2015 Feb; 104(2):536-47. PubMed ID: 25302696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of protein particles in parenteral solutions using micro-flow imaging.
    Huang CT; Sharma D; Oma P; Krishnamurthy R
    J Pharm Sci; 2009 Sep; 98(9):3058-71. PubMed ID: 18937372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Protein-Like Reference Material for Semiquantitatively Monitoring Visible Proteinaceous Particles in Biopharmaceuticals.
    Telikepalli S; Gonzalez K; Dragulin-Otto S; Ripple D; Carrier M; Khan M
    PDA J Pharm Sci Technol; 2019; 73(5):418-432. PubMed ID: 31209163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.